# OnCo record julien-hadoux (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/julien-hadoux/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "julien-hadoux" ;
  schema:name "Julien Hadoux"@en ;
  schema:description "Paris endocrine oncologist who was lead author of LIBRETTO-531, the trial that showed the selective RET inhibitor selpercatinib beats older kinase inhibitors as first treatment for advanced medullary thyroid cancer."@en ;
  schema:url <https://onco.cc/people/julien-hadoux/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "thyroid", "targeted-therapy", "trialist" ;
  schema:jobTitle "Endocrine oncologist, Gustave Roussy" ;
  schema:sameAs <https://orcid.org/0000-0002-1276-3289> ;
  onco:cancers <https://onco.cc/cancers/medullary-thyroid-cancer/>, <https://onco.cc/cancers/thyroid/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-libretto-531-nejm-2023/> ;
  schema:affiliation <https://onco.cc/institutions/gustave-roussy/> .